Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RANBP2-like and GRIP domain-containing protein 3 (RGPD3) is a protein encoded by the RGPD3 gene on human chromosome 2. It contains an N-terminal tetratricopeptide repeat (TPR) domain, two Ran-binding domains, and a C-terminal GRIP domain. The RGPD3 gene belongs to a cluster of Ran-binding protein–related genes created by primate-specific gene duplications. Its main paralog is RGPD4. Disease associations have been noted with some types of meningioma, but there is no evidence that RGPD3 itself is a therapeutic target or receptor. Its protein structure implies roles in protein-protein interaction and intracellular trafficking, but detailed functional or pharmacological characterization is lacking[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RANBP2-like and GRIP domain-containing protein 3 (RGPD3).